What counter-ion should I expect on a QYB ecnoglutide lot?

Setup, so nobody has to ask: QYB · ecnoglutide.

I have the document in front of me and I can read the numbers. What I cannot do is interpret them.

I am reasonably comfortable with statistics and completely uncomfortable with chromatography, or vice versa.

What does this actually establish, and what does it not?

The relevant arithmetic is that gross mass equals peptide plus counter-ion plus water, and the certificate usually reports only the first indirectly.

Peptides purified by reverse-phase chromatography with a trifluoroacetic acid mobile phase are isolated as trifluoroacetate salts. The trifluoroacetate content depends on the number of basic residues and can run from a few per cent to well over ten by mass on a heavily basic sequence.

Reconciling gross mass to label claim

More usefully, net peptide content — the fraction of gross mass that is the peptide itself — is the figure that folds water and counter-ion together and is what you should ask for if you ask for anything.

Ion chromatography and fluorine NMR are the accepted quantitative methods for trifluoroacetate, and neither is a chromatographic purity method.

The caveat is that a purity figure is completely blind to counter-ion content, and the two are routinely conflated.

Water plus counter-ion is why gross mass and peptide mass differ.

Answering this needs the purification method, since a trifluoroacetic acid mobile phase leaves trifluoroacetate unless a deliberate exchange was performed.

Quantification differs by ion: trifluoroacetate by ion chromatography or by fluorine nuclear magnetic resonance, acetate by ion chromatography or by capillary electrophoresis. Neither shows up on a UV chromatogram.

Concretely, the number of basic residues drives counter-ion load, because each protonated basic site pairs with one counter-ion. A sequence with several lysines and arginines carries proportionally more.

Trifluoroacetate effects in cell culture are documented and are the technical basis for salt exchange to acetate.

Trifluoroacetate unless a deliberate exchange was done. Ask which.

The short version: peptides are supplied as salts, the salt is real mass, and neither purity nor a chromatogram will tell you how much of it there is.

Trifluoroacetate has documented biological effects at higher concentrations in cell culture, which is the technical reason acetate exchange exists rather than a marketing one.

On the detail: a supplier who reports both water and counter-ion has given you everything needed to reconcile the vial, and on this site that is a very short list.

Peptides from reverse-phase purification with trifluoroacetic acid mobile phases are isolated as trifluoroacetate salts, which is standard synthesis practice.

Ask for net peptide content. It folds water and counter-ion into one usable number.

Start with which counter-ion the process produced, because trifluoroacetate from reverse-phase purification and acetate from a salt exchange behave differently and are quantified differently.

Acetate salts are produced by a deliberate ion exchange after purification. The exchange costs a processing step and is the reason acetate-form material is more expensive.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Purity says nothing about counter-ion. They are unrelated measurements.

Answer first: the counter-ion is part of the mass you paid for and none of the peptide you wanted, and it can run to several per cent or more.

Worked reconciliation: a 10 mg vial at four per cent water and eight per cent trifluoroacetate contains 10.0 × 0.88 = 8.8 mg of peptide, a twelve per cent shortfall against label with a perfectly clean purity figure.

Absence of a counter-ion figure is an absent measurement rather than a low one.

Count the basic residues and you can estimate the counter-ion load.